News
Dry eye is very common, especially post corneal refractive surgery, and should be treated preoperatively with attention paid ...
Alcon's Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.
3d
Zacks Investment Research on MSNAlcon Stock Gains Following UNITY VCS' Approval in CanadaAlcon Inc.’s ALC UNITY Vitreoretinal Cataract System (“VCS”) has recently received approval from Health Canada. UNITY VCS is the latest innovation from the Alcon Vision Suite — a portfolio of ...
According to a 2025 report on Cataract Surgery Devices Market by Mordor Intelligence, the global market is expected to grow from USD 8.90 billion in 2025 to USD 10.
Alcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) technology, has received CE Mark approval. The lens, made from Alcon's advanced ...
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity® , the most widely implanted9 extended depth of focus (EDOF) intraocular ...
Clareon ® Vivity ® Extended Vision Hydrophobic IOL with the AutonoMe ® – CE Mark Directions for Use. Alcon Data on File, 2024. World Health Organization. Cataract.
While Alcon's contact lens market share has been stable, lagging research and innovation could start to chip away at this.
Alcon, the global leader in eye care, announces that its AcrySof IQ Vivity and Clareon Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants ...
Alcon: Clareon PanOptix, which delivers exceptional clarity and offers spectacle independence across all distances with a patient satisfaction rate of 99.2 per cent. Clareon Vivity with wavefront ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results